These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1030286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII.
    Falk A, Fuchs GF.
    Chest; 1978 Jan; 73(1):44-8. PubMed ID: 340155
    [Abstract] [Full Text] [Related]

  • 4. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
    Fitzgerald DW, Morse MM, Pape JW, Johnson WD.
    Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
    [Abstract] [Full Text] [Related]

  • 5. [Preventive use of INH in patients with pulmonary fibrosis. Part II. Results of treatment. Discussion].
    Chwalibóg B.
    Pneumonol Pol; 1980 Sep; 48(9):589-99. PubMed ID: 7001389
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of INH prophylaxis on tuberculin reactions in children].
    Leśkiewicz H, Mozolewska H, Smreczyńska J, Warelis B.
    Gruzlica; 1968 Mar; 36(3):229-37. PubMed ID: 5663099
    [No Abstract] [Full Text] [Related]

  • 7. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC.
    Arch Intern Med; 1968 Mar; 157(15):1729-34. PubMed ID: 9250234
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of latent tuberculosis infection in patients aged > or =35 years.
    Gilroy SA, Rogers MA, Blair DC.
    Clin Infect Dis; 2000 Sep; 31(3):826-9. PubMed ID: 11017843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Late results and modern indications in INH chemoprophylaxis].
    Omodei-Zorini A.
    Gruzlica; 1968 Dec; 36(12):1265-70. PubMed ID: 5305034
    [No Abstract] [Full Text] [Related]

  • 14. [Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Mochizuki K, Shigeto E, Kobayashi Y, Nagasawa S.
    Kekkaku; 1987 May; 62(5):265-80. PubMed ID: 3626256
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Contact investigation and isoniazid chemoprophylaxis in New York City, 1979-1987.
    Vennema A.
    N Y State J Med; 1992 May; 92(5):185-8. PubMed ID: 1614668
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
    Wada M, Seita A, Mori T, Ogata H, Sugie T, Sugita H.
    Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.